Previous 10 | Next 10 |
Checkpoint Therapeutics (CKPT) entered into an equity distribution agreement dated December 17, 2020, providing for an at-the-market ("ATM") equity offering program, pursuant to a controlled equity offering sales agreement between the Company, Cantor Fitzgerald, Ladenburg...
Mesoblast (MESO) -31% after stem-cell therapy not likely to meet target for reducing mortality due to COVID-19.Wunong Net Technology Company (WNW) -18%.Applied DNA Sciences (APDN) -16% on Q4 earnings release.Takung Art (TKAT) -14%.Virgin Galactic Holdings (SPCE) -11%&...
Do You Agree With Analysts On These 3 Hot Penny Stocks? Penny stocks and small-cap stocks in general have seen a bit of a resurgence recently. What began as a mad dash for the next electric vehicle stock to buy has evolved into finding the next stocks under $5 to rally big. This...
44.0% objective response rate and 10.3-month median progression-free survival observed in non-small cell lung cancer (NSCLC) cohort Phase 3 registration -enabling trial planned in f irst -line metastatic NSCLC ...
Checkpoint Therapeutics (CKPT): Q3 GAAP EPS of -$0.09 misses by $0.01.Revenue of $0.03M (-89.3% Y/Y) misses by $0.16M.Cash and cash equivalents of $42M.Press Release For further details see: Checkpoint Therapeutics EPS misses by $0.01, misses on revenue
NEW YORK, Nov. 04, 2020 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immunotherapy and targeted oncology company focused on the acquisition, development and commercialization of novel treatments for patients with solid tumor...
DBV Technologies S.A. (DBVT) +80% as EMA approves Viaskin Peanut application.Endurance International Group Holdings (EIGI) +61% on announcing agreement to be acquired by Clearlake Capital Group L.P.AnPac Bio-Medical Science (ANPC) +30% as its Chinese company secu...
Checkpoint Therapeutics (CKPT) and Samsung Biologics expand their long-term manufacturing partnership for Checkpoint's anti-PD-L1 antibody, cosibelimab.Building upon an existing agreement entered into in 2017, Samsung Bio will provide additional commercial-scale drug substance manufactur...
Samsung Biologics and Checkpoint Therapeutics Expand Manufacturing Partnership for Cosibelimab PR Newswire INCHEON, South Korea and NEW YORK, Nov. 2, 2020 INCHEON, South Korea and NEW YORK , Nov. 2, 2020 /PRNewswire/ -- Samsung Biologics Co., Ltd. ("Samsu...
4 Names For Your Penny Stocks List Today It doesn’t matter if you’re looking at small cap penny stocks or larger cap ones, if they’re trending, someone’s watching. The name of the game with these cheap stocks is simple: make money quickly. Some choose...
News, Short Squeeze, Breakout and More Instantly...
Checkpoint Therapeutics Inc. Company Name:
CKPT Stock Symbol:
NASDAQ Market:
Checkpoint Therapeutics Inc. Website:
WALTHAM, Mass., July 25, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced that the U.S. Food and Drug Administration (“FDA”) has accepted for review Check...
Collaboration explores the potential synergistic effects of Checkpoint’s anti-PD-L1, cosibelimab, in combination with the autologous T cell therapy, Immuncell-LC YONGIN, South Korea and WALTHAM, Mass., July 15, 2024 (GLOBE NEWSWIRE) -- GC Cell (KRX: 144510.KS) and Checkpoin...
WALTHAM, Mass., July 02, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced it has entered into a definitive agreement with a single healthcare-dedicated institutional in...